Chiara Mercinelli

The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs

Marzia Del Re, Stefania Crucitta, Federico Paolieri et al. · Journal of Translational Medicine · 2022 · 21 citations · Full text

Vesical Imaging‐Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle‐invasive bladder cancer

Andrea Necchi, Giuseppe Basile, Ewan A. Gibb et al. · British Journal of Urology · 2023 · 18 citations · Full text

Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer

Roger Li, Luigi Nocera, Kyle Rose et al. · European Urology Oncology · 2024 · 17 citations

Comparative Effectiveness, Urology, Surgical Oncology +6

Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI

Giorgio Brembilla, Giuseppe Basile, Michele Cosenza et al. · Radiology · 2024 · 16 citations

First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer

Chiara Mercinelli, Marco Moschini, Antonio Cigliola et al. · Journal of Clinical Oncology · 2024 · 13 citations